![](/img/cover-not-exists.png)
Phase I trial of iodine 131-labeled COL-1 in patients with gastrointestinal malignancies: influence of serum carcinoembryonic antigen and tumor bulk on pharmacokinetics.
Yu, B, Carrasquillo, J, Milenic, D, Chung, Y, Perentesis, P, Feuerestein, I, Eggensperger, D, Qi, C F, Paik, C, Reynolds, J, Grem, J, Curt, G, Siler, K, Schlom, J, Allegra, CVolume:
14
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.1996.14.6.1798
Date:
June, 1996
File:
PDF, 1.01 MB
english, 1996